Customized Bone Allografts by 3D-printing
Launched by ISTITUTO ORTOPEDICO RIZZOLI · Jan 17, 2023
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The study is a double-blind randomized clinical trial and point to achieve a comparison of geometry and use in the operating room between manually modelled bone grafts and bone grafts modelled using CAD techniques and customized cutting guides realized with 3D printing.
In addition, two other objectives will be pursued: (1) to conduct a preliminary analysis of the management and production costs of customized bone grafts and of the generation process using VSP and 3D printing of models and surgical interventions aids such as sterilizable PSI and GSI; (2) to treat pediatric patients sufferi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • From 2 to 18 years old
- • Diagnosis of limbs musculoskeletal diseases
- • Need for uni- or poly-axial correction through one or more osteotomies
- • Need for massive bone graft to stabilize the correction
- • Consent to the processing of data
- Exclusion Criteria:
- • Patients who refuse the VSP study
- • Patients who do not undergo in-depth radiological examinations or patients with insufficient radiological documentation
- • Patients who undergo different interventions for the correction of musculoskeletal disease
- • Patients who do not need a massive bone graft
- • Pregnant women
About Istituto Ortopedico Rizzoli
Istituto Ortopedico Rizzoli is a renowned orthopedic research and treatment institute based in Bologna, Italy, dedicated to advancing musculoskeletal health through innovative clinical trials and cutting-edge medical practices. With a strong emphasis on research, the institute collaborates with leading experts in orthopedics, rehabilitation, and related fields to develop and evaluate new therapies and surgical techniques. Committed to improving patient outcomes, Istituto Ortopedico Rizzoli not only focuses on high-quality clinical care but also fosters a robust research environment that supports the translation of scientific findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Giovanni Trisolino, MD
Principal Investigator
IRCCS - Istituto Ortopedico Rizzoli
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials